Advanced search
Publication Cover
Clinical Ophthalmology Volume 16, 2022 - Issue
Submit an article Journal homepage
217
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cost Burden of Endothelial Keratoplasty in Fuchs Endothelial Dystrophy: Real-World Analysis of a Commercially Insured US Population (2014–2019)

Deepinder K Dhaliwal1 Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
Viktor Chirikov2 OPEN Health Evidence & Access, Bethesda, MD, USA
,
Jordana Schmier2 OPEN Health Evidence & Access, Bethesda, MD, USA
,
Sanika Rege2 OPEN Health Evidence & Access, Bethesda, MD, USA
&
Schalon Newton3 Trefoil Therapeutics, Inc., San Diego, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9141-9581
ORCID Icon
Pages 1055-1067 | Published online: 06 Apr 2022

References

  • Soh YQ, Kocaba V, Pinto M, Mehta JS. Fuchs endothelial corneal dystrophy and corneal endothelial diseases: east meets west. Eye. 2020;34(3):427–441. doi:10.1038/s41433-019-0497-9
  • Goldberg RA, Raza S, Walford E, Feuer WJ, Goldberg JL. Fuchs endothelial corneal dystrophy: clinical characteristics of surgical and nonsurgical patients. Clin Ophthalmol. 2014;8:1761–1766. doi:10.2147/OPTH.S68217
  • Elhalis H, Azizi B, Jurkunas UV. Fuchs endothelial corneal dystrophy. Ocul Surf. 2010;8(4):173–184. doi:10.1016/S1542-0124(12)70232-X
  • Eghrari AO, Gottsch JD. Fuchs’ corneal dystrophy. Expert Rev Ophthalmol. 2010;5(2):147–159. doi:10.1586/eop.10.8
  • Böhm M, Leon P, Wylęgała A, Ong Tone S, Condron T, Jurkunas U. Cost-effectiveness analysis of preloaded versus non-preloaded Descemet membrane endothelial keratoplasty for the treatment of Fuchs endothelial corneal dystrophy in an academic centre. Br J Ophthalmol. 2021;bjophthalmol-2020-317536. doi:10.1136/bjophthalmol-2020-317536
  • Bentley TS. U.S. Organ and Tissue Transplant Cost Estimates and Discussion. Milliman Research Report; Brookfield, WI: Milliman; 2014.
  • Blitzer AL, Colby KA. Update on the surgical management of fuchs endothelial corneal dystrophy. Ophthalmol Ther. 2020;9(4):757–765. doi:10.1007/s40123-020-00293-3
  • The Lewin Group, Inc. Cost-Benefit Analysis of Corneal Transplant. Eye Bank Association of America; 2013.
  • Zafar S, Wang P, Woreta FA, Aziz K, Makary M, Srikumaran D. Risk factors for repeat keratoplasty after endothelial keratoplasty in the medicare population. Am J Ophthalmol. 2021;221:287–298. doi:10.1016/j.ajo.2020.08.006
  • Gain P, Jullienne R, He Z, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167–173. doi:10.1001/jamaophthalmol.2015.4776
  • Bentley TS, Hanson SG. US organ and tissue transplant cost estimates and discussion. Milliman. Ref Type: Report. 2011.
  • Ortner NJ. US organ and tissue transplant cost estimates and discussion. Milliman. 7-28-2013. Ref Type: Report. 2005.
  • Guilbert E, Bullet J, Sandali O, Basli E, Laroche L, Borderie VM. Long-term rejection incidence and reversibility after penetrating and lamellar keratoplasty. Am J Ophthalmol. 2013;155(3):560–569.e2. doi:10.1016/j.ajo.2012.09.027
  • Ong HS, Ang M, Mehta J. Evolution of therapies for the corneal endothelium: past, present and future approaches. Br J Ophthalmol. 2021;105(4):454–467. doi:10.1136/bjophthalmol-2020-316149
  • Melles GRJ. Landmark study on Descemet stripping with endothelial keratoplasty: where has it led us? J Cataract Refract Surg. 2021;47(5):561–562. doi:10.1097/j.jcrs.0000000000000641
  • Kulaylat AS, Schaefer EW, Messaris E, Hollenbeak CS. Truven health analytics marketscan databases for clinical research in colon and rectal surgery. Clin Colon Rectal Surg. 2019;32(1):54–60. doi:10.1055/s-0038-1673354
  • Musch DC, Niziol LM, Stein JD, Kamyar RM, Sugar A. Prevalence of corneal dystrophies in the United States: estimates from claims data. Invest Ophthalmol Vis Sci. 2011;52(9):6959–6963. doi:10.1167/iovs.11-7771
  • Price MO, Feng MT, Price FW. Endothelial Keratoplasty update 2020. Cornea. 2021;40(5):541–547. doi:10.1097/ICO.0000000000002565
  • Gibbons A, Leung EH, Yoo SH. Cost-effectiveness analysis of Descemet’s membrane endothelial keratoplasty versus Descemet’s stripping endothelial keratoplasty in the United States. Ophthalmology. 2019;126(2):207–213. doi:10.1016/j.ophtha.2018.09.033
  • Thiel MA, Bochmann F, Schmittinger-Zirm A, Bänninger PB, Schmid MK, Kaufmann C. Komplikationen der Descemet Stripping Automatisierten Endothelkeratoplastik (DSAEK) [Complications of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)]. Ophthalmologe. 2015;112(12):969–973. doi:10.1007/s00347-015-0166-8
  • Sanchez PJ, Straiko MD, Terry MA. Complications of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) surgery. In: Cursiefen C, Jun A, editors. Current Treatment Options for Fuchs Endothelial Dystrophy. Springer, Cham;2017:189–204. doi:10.1007/978-3-319-43021-8_12
  • Rein DB, Wittenborn JS, Zhang P, et al. The economic burden of vision loss and blindness in the United States. Ophthalmology. 2021;120(9):1728–1735.
  • Matthaei M, Hribek A, Clahsen T, Bachmann B, Cursiefen C, Jun AS. Fuchs endothelial corneal dystrophy: clinical, genetic, pathophysiologic, and therapeutic aspects. Annu Rev Vis Sci. 2019;5:151–175. doi:10.1146/annurev-vision-091718-014852
  • Rocha-de-Lossada C, Rachwani-Anil R, Borroni D, et al. New horizons in the treatment of corneal endothelial dysfunction. J Ophthalmol. 2021;2021:6644114. doi:10.1155/2021/6644114

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.